PAM
ANIK icon

Panagora Asset Management’s Anika Therapeutics ANIK Stock Holding History

Panagora Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-165
Closed -$7K – 1734
2021
Q2 		$7K Buy
165
+2
+1% +$85 ﹤0.01% 2361
2021
Q1 		$7K Hold
163
– – ﹤0.01% 2493
2020
Q4 		$7K Buy
+163
New +$6.19K ﹤0.01% 2369
2017
Q3 		– Sell
-1,315
Closed -$65K – 2313
2017
Q2 		$65K Sell
1,315
-1,933
-60% -$89K ﹤0.01% 2003
2017
Q1 		$141K Sell
3,248
-26,681
-89% -$1.27M ﹤0.01% 1764
2016
Q4 		$1.47M Sell
29,929
-436
-1% -$20.2K 0.01% 1038
2016
Q3 		$1.45M Buy
30,365
+1,513
+5% +$74.7K 0.01% 1046
2016
Q2 		$1.55M Sell
28,852
-1,382
-5% -$65.1K 0.01% 957
2016
Q1 		$1.35M Buy
30,234
+27,397
+966% +$1.11M 0.01% 990
2015
Q4 		$108K Buy
2,837
+1,522
+116% +$58.2K ﹤0.01% 1776
2015
Q3 		$42K Sell
1,315
-2,931
-69% -$102K ﹤0.01% 2034
2015
Q2 		$140K Sell
4,246
-11,412
-73% -$407K ﹤0.01% 1830
2015
Q1 		$645K Buy
15,658
+10,087
+181% +$408K ﹤0.01% 1221
2014
Q4 		$227K Hold
5,571
– – ﹤0.01% 1578
2014
Q3 		$204K Sell
5,571
-2,444
-30% -$106K ﹤0.01% 1624
2014
Q2 		$371K Hold
8,015
– – ﹤0.01% 1502
2014
Q1 		$329K Hold
8,015
– – ﹤0.01% 1574
2013
Q4 		$306K Hold
8,015
– – ﹤0.01% 1537
2013
Q3 		$192K Hold
8,015
– – ﹤0.01% 1678
2013
Q2 		$135K Buy
+8,015
New +$116K ﹤0.01% 1780

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Panagora Asset Management's ANIK Position: Q3 2021 in Review

Panagora Asset Management sold out of Anika Therapeutics (ANIK) in Q3 2021, closing a stake of 165 shares — an estimated $7K sold.

Panagora Asset Management first reported a position in ANIK in Q2 2013 and held it in 20 quarters. The position peaked at $1.55M in Q2 2016. 131 funds tracked by Wall St. Rank hold ANIK as of Q3 2021.

  • Panagora Asset Management reported no remaining Anika Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 165 Anika Therapeutics shares in Q3 2021, an estimated $7K.
  • Panagora Asset Management first reported a position in Anika Therapeutics in Q2 2013 and held it in 20 quarters.
  • Panagora Asset Management's Anika Therapeutics position peaked at $1.55M in Q2 2016.
  • 131 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.